Literature DB >> 33478555

Non-SUMOylated CRMP2 decreases NaV1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15.

Kimberly Gomez1, Dongzhi Ran1, Cynthia L Madura1, Aubin Moutal1, Rajesh Khanna2,3.   

Abstract

Voltage-gated sodium channels are key players in neuronal excitability and pain signaling. Functional expression of the voltage-gated sodium channel NaV1.7 is under the control of SUMOylated collapsin response mediator protein 2 (CRMP2). When not SUMOylated, CRMP2 forms a complex with the endocytic proteins Numb, the epidermal growth factor receptor pathway substrate 15 (Eps15), and the E3 ubiquitin ligase Nedd4-2 to promote clathrin-mediated endocytosis of NaV1.7. We recently reported that CRMP2 SUMO-null knock-in (CRMP2K374A/K374A) female mice have reduced NaV1.7 membrane localization and currents in their sensory neurons. Preventing CRMP2 SUMOylation was sufficient to reverse mechanical allodynia in CRMP2K374A/K374A female mice with neuropathic pain. Here we report that inhibiting clathrin assembly in nerve-injured male CRMP2K374A/K374A mice precipitated mechanical allodynia in mice otherwise resistant to developing persistent pain. Furthermore, Numb, Nedd4-2 and Eps15 expression was not modified in basal conditions in the dorsal root ganglia (DRG) of male and female CRMP2K374A/K374A mice. Finally, silencing these proteins in DRG neurons from female CRMP2K374A/K374A mice, restored the loss of sodium currents. Our study shows that the endocytic complex composed of Numb, Nedd4-2 and Eps15, is necessary for non-SUMOylated CRMP2-mediated internalization of sodium channels in vivo.

Entities:  

Keywords:  CRMP2; Endocytosis; Eps15; NaV1.7; Nedd4-2; Neuropathic pain; Numb; Sumoylation

Year:  2021        PMID: 33478555      PMCID: PMC7819318          DOI: 10.1186/s13041-020-00714-1

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


  44 in total

Review 1.  Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons.

Authors:  Anthony M Rush; Theodore R Cummins; Stephen G Waxman
Journal:  J Physiol       Date:  2006-12-07       Impact factor: 5.182

Review 2.  Sodium channels in normal and pathological pain.

Authors:  Sulayman D Dib-Hajj; Theodore R Cummins; Joel A Black; Stephen G Waxman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

3.  Studies on CRMP2 SUMOylation-deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic pain.

Authors:  Aubin Moutal; Song Cai; Jie Yu; Harrison J Stratton; Aude Chefdeville; Kimberly Gomez; Dongzhi Ran; Cynthia L Madura; Lisa Boinon; Maira Soto; Yuan Zhou; Zhiming Shan; Lindsey A Chew; Kathleen E Rodgers; Rajesh Khanna
Journal:  Pain       Date:  2020-11       Impact factor: 6.961

Review 4.  Coordinating Synaptic Signaling with CRMP2.

Authors:  Harrison Stratton; Lisa Boinon; Aubin Moutal; Rajesh Khanna
Journal:  Int J Biochem Cell Biol       Date:  2020-05-08       Impact factor: 5.085

5.  Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain.

Authors:  Cédric J Laedermann; Matthieu Cachemaille; Guylène Kirschmann; Marie Pertin; Romain-Daniel Gosselin; Isabelle Chang; Maxime Albesa; Chris Towne; Bernard L Schneider; Stephan Kellenberger; Hugues Abriel; Isabelle Decosterd
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

Review 6.  Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.

Authors:  Joost P H Drenth; Stephen G Waxman
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.

Authors:  Tatiana Brustovetsky; Jessica J Pellman; Xiao-Fang Yang; Rajesh Khanna; Nickolay Brustovetsky
Journal:  J Biol Chem       Date:  2014-01-28       Impact factor: 5.157

8.  CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.

Authors:  Andrew D Piekarz; Michael R Due; May Khanna; Bo Wang; Matthew S Ripsch; Ruizhong Wang; Samy O Meroueh; Michael R Vasko; Fletcher A White; Rajesh Khanna
Journal:  Mol Pain       Date:  2012-07-24       Impact factor: 3.395

9.  Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells.

Authors:  N Klugbauer; L Lacinova; V Flockerzi; F Hofmann
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

10.  Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.

Authors:  Liberty François-Moutal; Erik T Dustrude; Yue Wang; Tatiana Brustovetsky; Angie Dorame; Weina Ju; Aubin Moutal; Samantha Perez-Miller; Nickolay Brustovetsky; Vijay Gokhale; May Khanna; Rajesh Khanna
Journal:  Pain       Date:  2018-10       Impact factor: 7.926

View more
  6 in total

1.  Mechanisms Underlying the Selective Therapeutic Efficacy of Carbamazepine for Attenuation of Trigeminal Nerve Injury Pain.

Authors:  Jorge Baruch Pineda-Farias; Emanuel Loeza-Alcocer; Vidhya Nagarajan; Michael S Gold; Raymond F Sekula
Journal:  J Neurosci       Date:  2021-08-26       Impact factor: 6.167

2.  Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats.

Authors:  Jiahe Li; Harrison J Stratton; Sabina A Lorca; Peter M Grace; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2022-12       Impact factor: 2.581

3.  Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain.

Authors:  Kathryn Braden; Harrison J Stratton; Daniela Salvemini; Rajesh Khanna
Journal:  Neurobiol Pain       Date:  2021-12-27

4.  The Antidiabetic Drug Metformin Regulates Voltage-Gated Sodium Channel NaV1.7 via the Ubiquitin-Ligase NEDD4-2.

Authors:  Alexandru-Florian Deftu; Paul Chu Sin Chung; Cédric J Laedermann; Ludovic Gillet; Marie Pertin; Guylène Kirschmann; Isabelle Decosterd
Journal:  eNeuro       Date:  2022-03-04

Review 5.  New Vistas in microRNA Regulatory Interactome in Neuropathic Pain.

Authors:  Yash Gada; Amitkumar Pandey; Nikita Jadhav; Saiprasad Ajgaonkar; Dilip Mehta; Sujit Nair
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 6.  SUMOylation and Major Depressive Disorder.

Authors:  Seok-Won Jeoung; Hyun-Sun Park; Zae Young Ryoo; Dong-Hyung Cho; Hyun-Shik Lee; Hong-Yeoul Ryu
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.